# BIO-651 Completion Summary — Email Approval Policy

**Issue:** [BIO-651](/BIO/issues/BIO-651) No Emails without Board Approval  
**Status:** ✅ Complete  
**Priority:** Critical  
**Completed:** 22 June 2026  
**Owner:** CEO

---

## Objective

Implement mandatory board approval process for ALL external emails from BioNixus, ensuring complete oversight of organizational communications before they reach external recipients.

**Board Directive:** "NO emails from any agent or communication to outside the organization without clearly getting approval from board and always mention what email will be used and the HTML template to be sent"

---

## Deliverables

### 1. Email Approval Policy (MANDATORY)

**File:** [`docs/ops/email-approval-policy.md`](./email-approval-policy.md)

**Key Requirements:**
- ❌ **Zero external emails without explicit board approval**
- 📋 **Required documentation:** Sender email, complete HTML template, recipient details, business justification, send date/time
- 🔄 **Approval workflow:** Paperclip issue → Board review → "APPROVED" comment → Send → Log outcome
- ⚠️ **Violations:** Immediate project pause + agent access revocation + board escalation
- ✅ **Effective immediately:** No grandfathering for in-progress campaigns

**Scope:**
- Business development outreach ✓
- Client communications ✓
- Vendor communications ✓
- Marketing emails ✓
- Transactional emails ✓
- Partnership inquiries ✓
- Support emails ✓

**Out of scope:**
- Internal team communications (emails between BioNixus employees/agents)

### 2. Approved Email Templates Registry

**Directory:** [`docs/ops/approved-email-templates/`](./approved-email-templates/)

**Purpose:** Central repository for board-approved email templates with approval metadata tracking

**Files Created:**
- `README.md` — Registry documentation and approval status tracker
- Directory structure ready for approved templates

**Template Approval Requirements:**
- Complete HTML file
- Approval metadata (`.md` file with approval date, issue reference, use case restrictions)
- Board approval comment on Paperclip issue
- Version control for template updates

### 3. Pending Template Approvals Tracker

**File:** [`docs/ops/pending-email-template-approvals.md`](./pending-email-template-approvals.md)

**Templates Identified:**
1. **GHE Email Sequence (8 templates)** — Global Health Exhibition Riyadh Oct 2026
   - T-90 Save-the-Date (28 July 2026) 🚨 **URGENT**
   - T-60 Email Follow-Up (27 Aug 2026)
   - T-45 CEO/COO Strategic Intro (11 Sept 2026)
   - T-30 Meeting Confirmation (26 Sept 2026)
   - T-14 Final Confirmation (12 Oct 2026)
   - Day 1 Post-Meeting Thank You
   - Day 7 Post-Meeting Follow-Up
   - T-60 LinkedIn Outreach

2. **Transactional Templates (2 templates)**
   - Welcome Email (`preview-welcome-email.html`)
   - Email Verification (`preview-verification-email.html`)

**Risk Alert:** GHE T-90 send date is 28 July 2026 (36 days from policy implementation). Approval needed by 26 July for CRM setup and contact verification.

---

## Approval Workflow Implementation

### For Agents Requesting Email Approval

```
1. Create Paperclip issue: "Email Approval: [Purpose] — [Recipient Company]"
2. Include required fields:
   - Email subject line
   - Sender email address (e.g., admin@bionixus.com)
   - Complete HTML template (inline or attached)
   - Recipient details (name, company, email)
   - Send date/time
   - Business justification
3. Assign to CEO for board review
4. Wait for "APPROVED" comment
5. Send email exactly as approved
6. Log send outcome on approval issue
```

### For Board Reviewing Email Requests

```
1. Review Paperclip issue for completeness
2. Evaluate email against criteria:
   - Brand alignment (tone, messaging, visual identity)
   - Legal compliance (privacy, anti-spam)
   - Strategic fit (supports company goals)
   - Risk assessment (reputational, client relationship)
   - Accuracy (fact-checking claims, data)
3. Post one of:
   - ✅ "APPROVED" — may send as-is
   - ⚠️ "CHANGES REQUESTED" + specify changes
   - ❌ "REJECTED" + explain reason
```

---

## Immediate Actions Required

### Critical (Next 48 Hours)

1. **Board:** Review and approve GHE T-90 template
   - Send date: 28 July 2026 (36 days away)
   - 8 pharma target accounts
   - First touch in exhibition outreach sequence
   - Source: `docs/bd/bio-615-outreach-email-templates.md`

2. **Board:** Clarify approval workflow preferences
   - Individual Paperclip issues per template? OR
   - Batch approval for full email sequences?
   - Who posts "APPROVED" comment (CEO, board member, specific role)?

### Short-term (Next 2 Weeks)

3. **Board:** Review remaining GHE templates (7 templates, send dates Aug–Oct 2026)

4. **Board:** Review transactional templates (welcome, verification)
   - Lower urgency if no active subscriber campaigns
   - Required before website contact form goes live

5. **CEO:** Socialize policy with all agents
   - Post policy announcement in agent channels
   - Require policy acknowledgment via comment
   - Monitor compliance

6. **All Agents:** Read and acknowledge Email Approval Policy
   - Post acknowledgment comment on BIO-651
   - Format: "I acknowledge that I have read and understand the Email Approval Policy (BIO-651). I will not send any external emails without explicit board approval. Agent: [Name], Date: [YYYY-MM-DD]"

---

## Compliance Status

| Component | Status | Notes |
|-----------|--------|-------|
| **Email Approval Policy** | ✅ Published | Mandatory for all agents |
| **Approved Templates Registry** | ✅ Ready | Empty — awaiting first approvals |
| **Pending Template Tracker** | ✅ Published | 9 templates identified |
| **GHE T-90 Template** | ⏳ Pending | Send date 28 July — 36 days |
| **GHE Remaining Templates** | ⏳ Pending | Send dates Aug–Oct 2026 |
| **Transactional Templates** | ⏳ Pending | Lower urgency |
| **Agent Acknowledgments** | 🚨 Required | 0 acknowledgments received |
| **Technical Controls** | ⏳ Future | API approval checks, automated compliance alerts |

---

## Risk Assessment

### High Risk

**GHE Campaign Timeline Jeopardy**
- **Issue:** T-90 send date is 28 July 2026 (36 days away)
- **Impact:** Missing T-90 window reduces exhibition ROI; prospects book meetings with competitors first
- **Mitigation:** Board prioritizes GHE T-90 approval within 48 hours
- **Fallback:** If approval delayed, push to T-60 (27 Aug) with condensed outreach timeline

### Medium Risk

**Agent Non-Compliance**
- **Issue:** Agents accustomed to autonomous email sending may violate policy
- **Impact:** Reputational damage, client relationship risk, policy undermined
- **Mitigation:** CEO socializes policy immediately; require written acknowledgment; monitor compliance
- **Fallback:** Agent access revocation on first violation (zero tolerance)

### Low Risk

**Approval Bottleneck**
- **Issue:** Board approval response time exceeds 48-hour target
- **Impact:** Email campaign delays, missed business opportunities
- **Mitigation:** Board clarifies urgent approval path; considers batch approvals for sequences
- **Fallback:** CEO empowered to approve on board's behalf for urgent requests (board-defined criteria)

---

## Policy Questions for Board Resolution

1. **Batch approval policy?**
   - Can full email sequences (e.g., GHE 8-template sequence) be approved as a package?
   - Or individual approval required per send?

2. **Pre-approval window?**
   - How far in advance can templates be approved? (e.g., approve October templates in June?)

3. **Urgent approval path?**
   - If urgent email opportunity arises (< 24hr), what is the expedited approval process?

4. **Template versioning?**
   - Do minor edits (typo fix, updated stat) require full re-approval?

5. **Automated transactionals?**
   - Do transactional emails (verification, password reset) require per-send approval or one-time template approval?

6. **CEO approval authority?**
   - Can CEO approve on board's behalf for defined categories (e.g., operational transactionals)?

---

## Success Criteria

- [x] Email Approval Policy published and effective
- [x] Approved Templates Registry created
- [x] Pending templates identified and documented
- [ ] All 9 pending templates board-approved or rejected (in progress)
- [ ] 100% agent policy acknowledgment (0% complete)
- [ ] Zero policy violations recorded
- [ ] GHE T-90 email approved and sent on 28 July 2026 (pending)

---

## Technical Controls Roadmap (Future Enhancement)

**Phase 1 — Email Gateway Approval Check (Technical)**
- API endpoint validates Paperclip issue approval before SMTP send
- Returns error if "APPROVED" comment not found on issue
- Prevents accidental sends of unapproved emails

**Phase 2 — Template Version Control (Operational)**
- Git-based template storage with approval tags
- Automated diffing for template change requests
- Approval metadata in git commit messages

**Phase 3 — Automated Compliance Monitoring (Governance)**
- Paperclip bot monitors for unapproved sends
- Real-time alerts to CEO/board on policy violations
- Weekly compliance dashboard

**Phase 4 — Approval Dashboard (User Experience)**
- Real-time view of pending/approved/rejected email requests
- Approval queue for board review
- SLA tracking (48-hour target)

**Implementation:** Scoped in separate technical issue after policy stabilizes.

---

## References

- Policy: [`docs/ops/email-approval-policy.md`](./email-approval-policy.md)
- Registry: [`docs/ops/approved-email-templates/`](./approved-email-templates/)
- Pending: [`docs/ops/pending-email-template-approvals.md`](./pending-email-template-approvals.md)
- GHE Templates: [`docs/bd/bio-615-outreach-email-templates.md`](../bd/bio-615-outreach-email-templates.md)
- Approval Tiers: [`docs/ops/flow4-approval-tier-thresholds.md`](./flow4-approval-tier-thresholds.md)
- Spend Governance: [`docs/ops/spend-governance.md`](./spend-governance.md)

---

## Sign-Off

| Role | Action | Date |
|------|--------|------|
| CEO | Policy implemented; agent notification required | 2026-06-22 |
| Board | Policy effective immediately; template reviews pending | 2026-06-22 |

---

**Status:** ✅ Policy implementation complete. Email approval enforcement active. Template approvals in progress.

**Next Critical Milestone:** Board approves GHE T-90 template by 26 July 2026 (36 days).
